Related Experiment Video
Updated: Jun 27, 2026
08:30
Surgical Retrieval, Isolation and In vitro Expansion of Human Anterior Cruciate Ligament-derived Cells for Tissue Engineering Applications
Published on: April 30, 2014
Editorial Commentary: Different Grafts, Different Problems: Why Anterior Cruciate Ligament Graft Selection Requires
Dylan Luxenburg1, Abid M Khan1, Bruce A Levy1
1Orlando Health Jewett Orthopedic Institute, Orlando, Florida, U.S.A.
Summary
Choosing the right anterior cruciate ligament graft involves patient factors. Quadriceps tendon grafts may have fewer donor site issues than bone-patellar tendon-bone grafts, but more research is needed.
Area of Science:
- Orthopedic surgery
- Sports medicine
- Biomedical engineering
Background:
- Anterior cruciate ligament (ACL) reconstruction graft selection is complex, requiring personalized approaches.
- Bone-patellar tendon-bone (BPTB) and quadriceps tendon (QT) grafts are common, with studies showing similar outcomes.
- Inconsistencies in reporting donor-site morbidity complicate graft comparison.
Purpose of the Study:
- To compare donor-site morbidity between BPTB and QT autografts for ACL reconstruction.
- To highlight the need for standardized reporting of donor-site morbidity in ACL graft research.
- To inform shared decision-making for optimal ACL graft selection.
Main Methods:
- Literature review of studies comparing BPTB and QT grafts for ACL reconstruction.
- Analysis of reported patient-reported outcomes, return-to-sport rates, and graft failure.
- Examination of methodologies used to assess donor-site morbidity across studies.
Main Results:
- Similar patient-reported outcomes, return-to-sport rates, and graft failure exist between BPTB and QT grafts.
- Emerging evidence suggests QT autografts may have lower donor-site morbidity compared to BPTB grafts.
- Significant variability exists in how donor-site morbidity is reported in current literature.
Conclusions:
- ACL graft choice necessitates individualized assessment and shared decision-making.
- Quadriceps tendon autografts present a potential advantage regarding donor-site morbidity.
- Standardized tools for assessing donor-site morbidity are crucial for future ACL graft research and clinical guidance.